Acorda Therapeutics, Inc. (ACOR) Financials

ACOR Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 366.3 million 307.4 million
2023-06-30 364.7 million 296.8 million
2023-03-31 374.9 million 297.9 million
2022-12-31 395.6 million 302.0 million

ACOR Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 7.4 million 141000
2023-06-30 -11.6 million 128000
2023-03-31 -7.0 million 71000
2022-12-31 9.1 million 173000

ACOR Net Income

No data available :(

ACOR Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 32.5 million - 5.0 million
2023-06-30 25.3 million - 5.3 million
2023-03-31 30.3 million - 5.6 million
2022-12-31 37.5 million - 5.9 million

ACOR Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 1.2 million
2023-06-30 1.2 million
2023-03-31 1.2 million
2022-12-31 2.2 million

ACOR Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 220000 1.2 million 23.2 million -
2023-06-30 - 1.6 million 21.8 million -
2023-03-31 - 1.4 million 22.5 million -
2022-12-31 14000 1.2 million 26.3 million -

ACOR Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 27.7 million 3.4 million
2023-06-30 29.7 million 3.1 million
2023-03-31 22.3 million 3.2 million
2022-12-31 31.5 million 4.6 million

ACOR

Price: $0.66

52 week price:
0.25
24.20

Payout Ratio Range:
-9.43%
69.24%

Earnings Per Share: -203.57 USD

P/E Ratio: 5.98

Exchange: NMS

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Volume: 250200

Ebitda: -218.1 million

Market Capitalization: 821028

Links: